First human doses of ORKA-001 given to healthy volunteers
Knowledge-focused
Completed
This study tested a single dose of a new drug called ORKA-001 in 24 healthy adults aged 18 to 65. The main goal was to check if the drug is safe and how the body processes it. No treatment for any disease was being tested—just basic safety information.
Phase: PHASE1 • Sponsor: Oruka Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:53 UTC